186 related articles for article (PubMed ID: 11280326)
1. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
Allison JE
N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
[No Abstract] [Full Text] [Related]
2. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
3. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting.
Janda M; Hughes KL; Auster JF; Leggett BA; Newman BM
J Gastroenterol Hepatol; 2010 Oct; 25(10):1661-7. PubMed ID: 20880176
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
[No Abstract] [Full Text] [Related]
5. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
Sung J
Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
[No Abstract] [Full Text] [Related]
6. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
Bond JH
Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
[No Abstract] [Full Text] [Related]
7. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
Skitek M
Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
[No Abstract] [Full Text] [Related]
8. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
Ottó S
Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
[TBL] [Abstract][Full Text] [Related]
9. Fecal-occult-blood test screening for colorectal cancer.
Zacks M
J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
[No Abstract] [Full Text] [Related]
10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
11. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
12. Fecal occult blood testing options.
Lastella VP
Gastroenterology; 2006 Jan; 130(1):285; author reply 285. PubMed ID: 16401498
[No Abstract] [Full Text] [Related]
13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal cancer.
Young GP
Jpn J Cancer Res; 1996 Dec; 87(12):inside front cover. PubMed ID: 9045951
[No Abstract] [Full Text] [Related]
15. Experiences in providing a screening service for colorectal cancer from a pathology laboratory.
Edwards JE; Williams JA; Thomas DW
Pathology; 2004 Aug; 36(4):330-4. PubMed ID: 15370132
[TBL] [Abstract][Full Text] [Related]
16. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
17. Lower specificity of occult-blood test on stool collected by digital rectal examination.
Zhang B; Nakama H; Fattah AS; Kamijo N
Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
[TBL] [Abstract][Full Text] [Related]
18. [Individual screening for colorectal cancer: which strategy for which patient?].
Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
[TBL] [Abstract][Full Text] [Related]
19. Colon cancer screening: the good, the bad, and the ugly.
Roy HK; Backman V; Goldberg MJ
Arch Intern Med; 2006 Nov; 166(20):2177-9. PubMed ID: 17101934
[No Abstract] [Full Text] [Related]
20. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
Winawer SJ; Fleisher M
Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
